Article
[Research Advance of Gene Mutation and Targeted Drug Therapy in Childhood Acute Myeloid Leukemia --Review].
Zhongguo shi yan xue ye xue za zhi - 1 Apr 2022
DU Cheng-Kan, Lu Ying
Abstract excerpt
The clinical therapeutic regimen for acute myeloid leukemia (AML) is not significantly different between adults and children, which is mostly based on IA (idarubicin and cytosine arabinoside) induction chemotherapy. With the rapid development of sequencing technique, people's understandings towards the molecular and biological abnormalities of AML are increasing, diverse AML gene mutation-based targeted drugs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
